Lewis and Sumner syndrome following infliximab treatment in Crohn's disease: A report of 2 cases

Inflammatory Bowel Diseases

Volumn 16, Issue 9, 2010, Pages 1450-1453

  Nancey, Stephane ^a,b   Bouhour, Françoise ^c   Boschetti, Gilles ^a,b   Magnier, Christophe ^d   Gonneau, Pierre Marie ^a   Souquet, Jean Christophe ^e   Kaiserlian, Dominique ^b   Flourie, Bernard ^a,b  

^a CENTRE HOSPITALIER LYON SUD   (France)

^b University Lyon i   (France)

^c HÔPITAL NEUROLOGIQUE   (France)

^d CENTRE HOSPITALIER SAINT JOSEPH SAINT LUC   (France)

^e CROIX ROUSSE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ANTINUCLEAR ANTIBODY; AZATHIOPRINE; C REACTIVE PROTEIN; GANGLIOSIDE GM1 ANTIBODY; IMMUNOGLOBULIN; INFLIXIMAB; MESALAZINE; METHOTREXATE; PREDNISOLONE;

ABDOMINAL PAIN; ACUTE PANCREATITIS; ADULT; ANUS FISTULA; ARM; ARTHRALGIA; BICEPS BRACHII MUSCLE; CASE REPORT; COSMETIC SIDE EFFECT; CROHN DISEASE; DEMYELINATING NEUROPATHY; DISEASE EXACERBATION; DISTAL PARESTHESIA; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELECTROPHYSIOLOGY; EXTENSOR DIGITORUM LONGUS MUSCLE; FEMALE; HUMAN; HYPESTHESIA; IRIDOCYCLITIS; LEG; LETTER; LEWIS AND SUMNER SYNDROME; MEDIAN NERVE; MOTOR DYSFUNCTION; MOTOR NERVE CONDUCTION; MUSCLE ACTION POTENTIAL; MUSCLE WEAKNESS; NERVE BLOCK; NEUROLOGIC EXAMINATION; PARESTHESIA; PERIANAL ABSCESS; PERONEUS NERVE PARALYSIS; PRIORITY JOURNAL; RECURRENT DISEASE; REMISSION; SIDE EFFECT; SURGICAL DRAINAGE; TENDON REFLEX; THIGH; TREATMENT RESPONSE; ULNAR NERVE; WALKING DIFFICULTY; WEIGHT GAIN;

ADULT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; CROHN DISEASE; DEMYELINATING DISEASES; FEMALE; HUMANS; MOTOR NEURON DISEASE; PERIPHERAL NERVOUS SYSTEM DISEASES; SYNDROME; TREATMENT OUTCOME;

EID: 77956292634     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21202     Document Type: Letter

References (8)

1. Lewis RA, Sumner AJ, Brown MJ, et al. Multifocal demyelinating neuropathy with persistent conduction block. Neurology. 1982;32:958-964.
2. Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology. 1991;41:617-618.
3. Hooper DR, Tarnopolsky MA, Baker SK. Lewis-Sumner syndrome associated with infliximab therapy in rheumatoid arthritis. Muscle Nerve. 2008;38:1318-1325.
4. Cocito D, Bergamasco B, Tavella A, et al. Multifocal motor neuropathy during treatment with infliximab. J Periph Nerve Syst. 2005;10:386-387.
5. Rodriguez-Escalera C, Belzunegui J, Lopez-Dominguez L, et al. Multifocal motor neuropathy with conduction block in a patient with rheumatoid arthritis on infliximab therapy. Rheumatology. 2005;44:132-133.
6. Singer OC, Otto B, Steinmetz H, et al. Acute neuropathy with multiple conduction blocks after monoclonal antibody therapy. Neurology. 2004;63:1754.
7. Tektonidou MG, Serelis J, Skopouli FN. Peripheral neuropathy in two patients with rheumatoid arthritis receiving infliximab treatment. Clin Rheumatol. 2007;26:258-260.
8. Richez C, Blanco P, Lagueny A, et al. Neuropathy resembling CIDP in patients receiving tumor necrosis factor a blockers. Neurology. 2005;64:1468-1470.